Opthea
Entry
2022
Hold
4yr
Status
Active
Who owns Opthea?
Opthea is currently owned by Abingworth through Abingworth Clinical Co-Development Fund 2 (2021 vintage), since 2022.
Hand-verified · updated 2026-07-08
More from Abingworth Clinical Co-Development Fund 2
Other portfolio companies in the same fund.
USMore Abingworth portfolio companies
From the same investor, across funds.
UK
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Opthea
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Opthea?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Opthea.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue